XML 92 R77.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stockholders' (Deficit) Equity - Restricted Stock Activity (Details) - Restricted Stock [Member] - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 12, 2016
Sep. 30, 2016
Mar. 10, 2016
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]            
Beginning balance, Number of Shares       524,870 401,534 363,171
Granted, Number of Shares 952,000 200,000 559,000 1,711,000 507,000 196,500
Vested, Number of Shares       (222,495) (133,874) (116,890)
Forfeited, Number of Shares       (402,000) (249,790) (41,247)
Ending balance, Number of Shares       1,611,375 524,870 401,534
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]            
Beginning balance, Weighted Average Grant Date Fair Value       $ 5.06 $ 9.38 $ 10.08
Granted, Weighted Average Grant Date Fair Value (in dollars per share)       2.48 4.27 8.47
Vested, Weighted Average Grant Date Fair Value       4.59 9.20 9.82
Forfeited, Weighted Average Grant Date Fair Value       3.39 8.19 9.92
Ending balance, Weighted Average Grant Date Fair Value       $ 2.80 $ 5.06 $ 9.38
Stock-based compensation expense       $ 1,155 $ 842 $ 1,367
Tax benefit       496 321 648
Grant Date Fair Value $ 2,475 $ 618 $ 1,152 4,245 $ 2,166 $ 1,663
Unrecognized compensation cost related to stock options       $ 3,702    
Unrecognized compensation cost related to restricted stock, recognition period       2 years 8 months 9 days    
Minimum [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]            
Award vesting period (in years)       3 years    
Maximum [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]            
Award vesting period (in years)       4 years